Clinical Trial Update: Safety and Efficacy of Interferon-Beta-1a (Rebif®) for Treating Subjects With Acute Symptoms of Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of Interferon-Beta-1a (Rebif) in treating acute symptoms of Ulcerative Colitis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Interferon-Beta-1a (Rebif) (Interferon beta-1a)

Snippet

Sponsor: EMD Serono | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED